Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
about
Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosusAutoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and futureContribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity.Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais.Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases.Triggers for anti-chromatin autoantibody production in SLE.Fcgamma receptors in the initiation and progression of systemic lupus erythematosus.Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.Novel Autoantigens Associated with Lupus Nephritis.The clinical utility of anti-chromatin antibodies as measured by BioPlex 2200 in the diagnosis of systemic lupus erythematosus versus other rheumatic diseasesQuantitation of autoantibodies in systemic autoimmune diseases: clinically useful?Anti-chromatin (anti-nucleosome) antibodies.Circulating nucleosomes due to a defective clearance of dying cells: consequences for systemic lupus erythematosus.A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis.Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal studySerum antinucleosome-specific antibody as a marker of autoimmunity in children with autism.Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study.Biomarkers for lupus nephritis: a critical appraisal.The origin and pathogenic consequences of anti-dsDNA antibodies in systemic lupus erythematosus.Clearing the complexity: immune complexes and their treatment in lupus nephritis.The spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease.The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: a systematic review and meta-analysis.Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.IgG4 autoantibodies induce dermal-epidermal separationCell lines that express membrane-associated DNA for anti-DNA antibody detection.Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis.Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients.Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus.Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.Nucleosomal DNA fragments in autoimmune diseases.Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
P2860
Q26796871-7FFC8228-37EB-4777-B934-4689994CDFB0Q33601679-E1C40276-1638-4368-A23C-1D3F73B4B0CCQ33933077-D906FBCC-670F-47D2-B7F2-D0CEEED841F3Q34004618-96DDA970-5B93-4CBF-BF6A-B6E52B2C3C9CQ34197831-53740AB1-952A-424F-B0C9-CB20AB4DA123Q35038880-29E5091A-14EC-494B-AC0E-2A2059A1395FQ35045914-7A94A904-8504-4AD3-B3E3-D836CFDDFFF1Q35216982-13381A86-4D09-4DD4-9A8E-987A8A2C22BDQ35552703-19213440-C377-440F-B3EE-1F06180D0D62Q35555256-61752FC1-9988-4492-B6AE-2354FDFC6104Q35555309-469665F8-427E-478F-8BED-2791028DE8BFQ35670637-49C03AB5-CF7C-4C50-898D-676CD822F6F4Q36238497-28E954B0-66B2-49D4-AD66-062F32B006E4Q36560767-C499D1DD-536F-4703-93A8-468551C4CD83Q36560777-77F9795F-5C4A-4BF1-8EF1-D3FD318998B0Q36827945-F100A9B7-87CF-4B67-A13D-D0266D477522Q37354195-61A70821-E5ED-469D-8F56-DDDDAEF769DFQ37453929-2BDA661D-2DE6-4E00-B964-B80F55B89793Q37688416-4DC4A1CF-5437-4A1A-9CF1-66232C955A9CQ37690046-AD19AF3B-A4E7-4EE2-9D84-5C8C95895028Q37736277-E43D2B04-2CA2-49BC-B40B-6E7E8202E479Q37754520-8BD2D7BD-10A4-45AB-BB1A-17A3866A6590Q37892917-7E4ACF05-BF8C-48FB-B079-9A04ED9BC918Q38209945-844C44E2-819E-4AB3-A2CD-D6C596730AF1Q38269214-08B5B506-1079-42FE-AF9E-45A19B8DAAC8Q39608198-BBEFA48F-9FF1-4A2A-83F1-ED914A66F0F6Q39740759-49033C12-B408-491D-85E2-EEC40F8F4D0AQ39964403-03266678-E523-4B02-AFC5-750457D92C3CQ44520690-673F33D7-FCEE-4A9F-ABBB-0A7BFB743341Q45739101-C845D46E-9335-48D0-B0D7-96A769A78421Q46397634-C4AEDA04-6163-4448-BE81-455E55C85BB7Q46485635-719FF3C9-5524-4F30-BFBA-E45BC60378D0Q46721516-F8DEDF07-7BA5-4180-9EEE-CCD229F3EDE5Q47329854-4C22C609-2D73-44F8-B57A-54525884DA0CQ47777415-E42FE887-6B47-47BA-944C-EEF24E38E042Q51824317-F08CFF77-A94A-4ECF-BA7E-536FA1BCD635Q51928705-69E6E145-B54A-4D3F-8A76-63F6FAA5797BQ51934347-9456ACD2-E2E5-4413-AFEA-5599392477FFQ52597638-0C270DBB-CAB1-4379-ACB1-85D5AC96B470Q53217193-89B11CE5-5022-4D33-BBE2-96C949F0423B
P2860
Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Presence of antinucleosome aut ...... systemic lupus erythematosus.
@en
Presence of antinucleosome aut ...... systemic lupus erythematosus.
@nl
type
label
Presence of antinucleosome aut ...... systemic lupus erythematosus.
@en
Presence of antinucleosome aut ...... systemic lupus erythematosus.
@nl
prefLabel
Presence of antinucleosome aut ...... systemic lupus erythematosus.
@en
Presence of antinucleosome aut ...... systemic lupus erythematosus.
@nl
P2093
P2860
P50
P921
P1476
Presence of antinucleosome aut ...... systemic lupus erythematosus.
@en
P2093
P2860
P356
10.1002/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO;2-I
P577
2000-01-01T00:00:00Z